To investigate if API targets miR-155 and regulates SHIP-1 expression in the BM and tumor of an OPC mouse model, OPC mice were treated with API at a dose of 25 mg/kg (IP) 3 times per week for 2–3 weeks. Here, INPP5D is linked to neoplasm.